Filing Details

Accession Number:
0001209191-11-004752
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-01-24 20:47:49
Reporting Period:
2011-01-21
Filing Date:
2011-01-24
Accepted Time:
2011-01-24 20:47:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1107332 Dendreon Corp DNDN Pharmaceutical Preparations (2834) 223203193
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1420482 W Mark Frohlich 3005 First Avenue
Seattle WA 98121
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-01-20 21,038 $0.00 204,754 No 4 A Direct
Common Stock Disposition 2011-01-21 2,250 $35.27 202,504 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. This restricted stock award vest as follows: 25% on the first year anniversary and 6.25% quarterly thereafter.
  2. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person